Short description
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
Description
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.
The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initial internal focus in oncology and immunotherapies.
Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.
Last funding
Cannot Access
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
January 1, 2015
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Blurry Noaccess, Cannot Access, Noway Youcantaccess, Uh Ohhhh, Noaccess, Noaccess, No Way
Sign in for full access
Founders
Nikolai Kley